Company Performance: Revenue, profit margins, and overall financial health directly impact investor confidence and stock price.

Industry Trends: The growth or decline of the pharmaceutical and healthcare industry affects the demand for the company's products and services.

Regulatory Changes: Government regulations, drug approvals, and healthcare policies can significantly influence the company's future prospects.

Market Sentiment: Overall investor mood and risk appetite in the stock market can impact the buying and selling pressure on 600261.SHG.

Economic Conditions: Macroeconomic factors like inflation, interest rates, and economic growth can indirectly affect company performance and stock value.

Competitor Activity: Actions of rival companies, such as product launches or strategic alliances, can impact market share and profitability.

Global Events: Major global events, pandemics, or geopolitical tensions can disrupt supply chains and affect overall market stability.

News and Announcements: Company-specific news regarding product developments, clinical trial results, or mergers and acquisitions influences investor perception.

Dividend Policy: Dividend payouts and policies can attract or deter investors depending on their investment strategy and income needs.

Analyst Ratings: Reports and ratings from financial analysts can sway investor confidence and lead to shifts in trading volume.

Technological Advancements: Breakthroughs in pharmaceutical technology and healthcare innovation can impact the company's competitiveness.

Supply Chain Disruptions: Difficulties in sourcing raw materials or manufacturing components can affect production and revenue.

Investor Relations: Effective communication and transparency from the company to its investors can enhance trust and stability.